India’s BharatGPT: A Responsible AI Solution for Sensitive Data Handling

Date:

India has unveiled its very own ChatGPT rival called BharatGPT. Developed by CoRover.ai, an AI startup supported by the Department of Science and Technology, Government of India, BharatGPT aims to provide a responsible and accurate approach to handling sensitive information. With its lightweight design, BharatGPT offers swift and efficient implementation, making it a promising solution for various tasks. Integrated with CoRover’s Conversational AI platform, BharatGPT utilizes a multi-layered approach, incorporating deep learning with generative AI, supervised learning, AIML, and context-based auto-suggestion. Saurabh Kumar Chaubey, the CEO of iHUBAnubhuti – IIITD Foundation, believes that BharatGPT will have a significant impact across different sectors. India’s foray into the world of generative AI not only supports the local economy but also ensures regulatory compliance and enhances trust.

See also  OpenAI Unveils ChatGPT Team Subscription and GPT-4 with Vision for Image Recognition: Priority Access, Data Control, and Customizability

Frequently Asked Questions (FAQs) Related to the Above News

Please note that the FAQs provided on this page are based on the news article published. While we strive to provide accurate and up-to-date information, it is always recommended to consult relevant authorities or professionals before making any decisions or taking action based on the FAQs or the news article.

Share post:

Subscribe

Popular

More like this
Related

Obama’s Techno-Optimism Shifts as Democrats Navigate Changing Tech Landscape

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.